Sonova (OTCMKTS:SONVY) Shares Gap Down - Should You Sell?

Key Points

• Sonova shares gapped down about 5.9%, opening at $49.18 after a $52.17 close and last trading at $49.28 on light volume (≈3,515 shares).
• Analyst coverage is mixed but the consensus is a Hold (1 Strong Buy, 1 Buy, 4 Hold, 2 Sell), with recent upgrades from Zacks (to Hold) and RBC (to Moderate Buy).
• Key fundamentals/technicals: quick ratio 0.91, current ratio 1.24, debt/equity 0.51, and the stock is trading below its 50‑day ($53.02) and 200‑day ($54.01) moving averages.

Sonova Holding (OTCMKTS:SONVY - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $52.17, but opened at $49.18. Sonova shares last traded at $49.28, with a volume of 3,515 shares trading hands.

Analysts Set New Price Targets

Several research analysts have recently commented on SONVY shares. Zacks Research upgraded Sonova from a "strong sell" rating to a "hold" rating in a report on Monday, February 9th. Royal Bank Of Canada raised Sonova to a "moderate buy" rating in a research note on Tuesday, November 18th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold".

Sonova Trading Down 5.9%

The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. The company has a 50 day moving average of $53.02 and a 200-day moving average of $54.01.

Sonova Company Profile

Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.